ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Stem cell transplant : One year later, donor and recipient meet – The Indian Express

Continue reading

2017-04-12 Michael Zand NEWS

Dr. Gordon on Toxicities With Immunotherapy in Osteosarcoma – OncLive

OncLiveDr. Gordon on Toxicities With Immunotherapy in OsteosarcomaOncLiveNancy Gordon, MD, a pediatric oncologist and research assistant at The University of Texas MD Anderson Cancer Center, discusses toxicities associated with immunotherapy agents for… Continue reading

2017-04-11 Michael Zand NEWS

‘Unsafe’ Stem-Cell Eye Injections Draw Rebuke, Prompt Settlements – Daily Business Review (registration)


The Indian Express

Stem cell transplant : One year later, donor and recipient meet
The Indian Express
“Gauri was being treated at a Sector 32 hospital in Chandigarh and later we visited Dr Joseph John, Prof and head of Hematology department CMC as we were keen for a stem cell transplant. In early 2014, we found a donor and later in October 15, 2014, …

and more »

Continue reading

2017-04-11 Michael Zand NEWS

Dr. Slovin on Immunotherapy Agents for Prostate Cancer – OncLive

OncLiveDr. Slovin on Immunotherapy Agents for Prostate CancerOncLiveSusan F. Slovin, MD, PhD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses potential immunotherapy agents for patients with prostate cancer. Immunotherapy in prost… Continue reading

2017-04-11 Michael Zand NEWS

Gene Therapy May Help Those With Hearing Loss – Healthline

HealthlineGene Therapy May Help Those With Hearing LossHealthlineResearchers may have brought us one step closer to gene therapy for the treatment of hearing loss, after discovering a way to regenerate auditory hair cells in mice. It is estimated that … Continue reading

2017-04-11 Michael Zand NEWS

Identifying a Novel Target for Cancer Immunotherapy – Northwestern University NewsCenter


Daily Business Review (registration)

‘Unsafe’ Stem–Cell Eye Injections Draw Rebuke, Prompt Settlements
Daily Business Review (registration)
Coral Gables law firm Grossman Roth Yaffa Cohen filed lawsuits on behalf of the two patients, both over age 70, who traveled to Sunrise and paid $5,000 each for what they believed was stem–cell therapy that would help with age-related vision loss.

and more »

Continue reading

2017-04-11 Michael Zand NEWS

Quest Management Inc. Signs Letter of Intent to Acquire Immunotherapy Biotech Company Stemvax, Inc – Yahoo Finance

Identifying a Novel Target for Cancer Immunotherapy
Northwestern University NewsCenter
Immunotherapy is a type of cancer treatment that stimulates the patient’s own immune system to attack cancer cells. One immunotherapy approach involves targeting a group of proteins, called immune checkpoints, that normally prevents the immune system …

Continue reading

2017-04-11 Michael Zand NEWS

Quest Management Inc. Signs Letter of Intent to Acquire … – Nasdaq – Nasdaq

Quest Management Inc. Signs Letter of Intent to Acquire … – NasdaqNasdaqMADONA, Latvia, April 11, 2017– Quest Management Inc. announces the signing of a Letter of Intent to acquire immunotherapy Biotech company Stemvax,.and more &raquo… Continue reading

2017-04-11 Michael Zand NEWS
  • 1
  • …
  • 1,857
  • 1,858
  • 1,859
  • 1,860
  • 1,861
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Quest Management Inc. Signs Letter of Intent to Acquire Immunotherapy Biotech Company Stemvax, Inc
Yahoo Finance
MADONA, Latvia, April 11, 2017 (GLOBE NEWSWIRE) — Quest Management Inc. (QSMG) announces the signing of a Letter of Intent (the “Agreement”) to acquire immunotherapy Biotech company Stemvax, Inc., from Dr. Dwain Morris-Irvin PhD. Upon Closing …

and more »